On July 6, 2020, Humanigen, Inc. (the “Company”) applied to have its common stock approved for listing on the Nasdaq Capital Market.
July 15, 2020 (CytoDyn” or the “Company”), ... announced today it recently filed a comprehensive listing application package with The Nasdaq Stock Market to request an uplisting of the Company’s common stock.
Humanigen was approved today. 2 weeks between the 2 filings.